Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responsesAmrendra Kumar, Anna E. Vilgelm, Vijay Ramani et al.|Journal for ImmunoTherapy of Cancer|2023Cited by 22